Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 33, Issue 2, Pages 314-325Publisher
WILEY
DOI: 10.1002/immu.200310005
Keywords
GFP; Vav-iCre; hCD2-iCre; hematopoiesis; lymphocyte; transgenic
Categories
Funding
- MRC [MC_U117565359] Funding Source: UKRI
- Medical Research Council [MC_U117565359] Funding Source: Medline
- Medical Research Council [MC_U117565359] Funding Source: researchfish
Ask authors/readers for more resources
Bacteriophage P1 Cre/IoxP based systems can be used to manipulate the genomes of mice in vivo and in vitro, allowing the generation of tissue-specific conditional mutants. We have generated mouse lines expressing Cre recombinase in hematopoietic tissues using the vav regulatory elements, or in lymphoid cells using the hCD2 promoter and locus control region (LCR). The R26R-EYFP Cre reporter mouse line was used to determine the pattern of Cre expression in each line and enabled the assessment of Cre activity at a single-cell level. Analysis showed that the vav promoter elements were able to direct Cre-mediated recombination in all cells of the hematopoietic system. The hCD2 promoter and LCR on the other hand were able to drive Cre-mediated recombination only in T cells and B cells, but not in other hematopoietic cell types. Furthermore, in the appropriate tissues, deletion of the floxed target was complete in all cells, thereby excluding the possibility of variegated expression of the Cre transgene. Both of these Cre-transgenic lines will be useful in generating tissue-specific gene deletions within all the cells of hematopoietic or lymphoid tissues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available